Cargando…
The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour.
Regional chemotherapy for colorectal liver metastases has not demonstrated a convincing survival benefit over systemic chemotherapy. This may be due to poor delivery of chemotherapeutic drugs to hypovascular liver tumour. Since vasoactive agents may influence hepatic blood flow this study investigat...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972334/ https://www.ncbi.nlm.nih.gov/pubmed/2021531 |
_version_ | 1782135006258266112 |
---|---|
author | Hemingway, D. M. Cooke, T. G. Chang, D. Grime, S. J. Jenkins, S. A. |
author_facet | Hemingway, D. M. Cooke, T. G. Chang, D. Grime, S. J. Jenkins, S. A. |
author_sort | Hemingway, D. M. |
collection | PubMed |
description | Regional chemotherapy for colorectal liver metastases has not demonstrated a convincing survival benefit over systemic chemotherapy. This may be due to poor delivery of chemotherapeutic drugs to hypovascular liver tumour. Since vasoactive agents may influence hepatic blood flow this study investigated the effects of systemic and regional vasoconstrictors on the delivery of a regionally delivered marker in an experimental model of liver tumour. Systemic administration of angiotensin II caused a significant retention of marker in normal liver, but not in tumour compared to controls. Regional delivery of angiotensin II and phenylephrine caused significantly greater retention of marker in tumour than liver with an overall 4-fold increased retention of marker one minute after its injection. Ninety minutes after injection there was still significant retention of marker compared to control animals. Regional delivery of hepatic artery vasoconstrictors increase delivery of marker and may increase delivery of chemotherapeutic drug to liver tumour. |
format | Text |
id | pubmed-1972334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1991 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19723342009-09-10 The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. Hemingway, D. M. Cooke, T. G. Chang, D. Grime, S. J. Jenkins, S. A. Br J Cancer Research Article Regional chemotherapy for colorectal liver metastases has not demonstrated a convincing survival benefit over systemic chemotherapy. This may be due to poor delivery of chemotherapeutic drugs to hypovascular liver tumour. Since vasoactive agents may influence hepatic blood flow this study investigated the effects of systemic and regional vasoconstrictors on the delivery of a regionally delivered marker in an experimental model of liver tumour. Systemic administration of angiotensin II caused a significant retention of marker in normal liver, but not in tumour compared to controls. Regional delivery of angiotensin II and phenylephrine caused significantly greater retention of marker in tumour than liver with an overall 4-fold increased retention of marker one minute after its injection. Ninety minutes after injection there was still significant retention of marker compared to control animals. Regional delivery of hepatic artery vasoconstrictors increase delivery of marker and may increase delivery of chemotherapeutic drug to liver tumour. Nature Publishing Group 1991-04 /pmc/articles/PMC1972334/ /pubmed/2021531 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Hemingway, D. M. Cooke, T. G. Chang, D. Grime, S. J. Jenkins, S. A. The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. |
title | The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. |
title_full | The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. |
title_fullStr | The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. |
title_full_unstemmed | The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. |
title_short | The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. |
title_sort | effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972334/ https://www.ncbi.nlm.nih.gov/pubmed/2021531 |
work_keys_str_mv | AT hemingwaydm theeffectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour AT cooketg theeffectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour AT changd theeffectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour AT grimesj theeffectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour AT jenkinssa theeffectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour AT hemingwaydm effectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour AT cooketg effectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour AT changd effectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour AT grimesj effectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour AT jenkinssa effectsofintraarterialvasoconstrictorsonthedistributionofaradiolabelledlowmolecularweightmarkerinanexperimentalmodeloflivertumour |